Dr. Umar

This review explains how ZnT8 autoantibodies refine type 1 diabetes prediction and classification, emphasizing late-appearing epitope spreading, genotype-shaped epitope specificity, and rapid post-diagnosis decline. It also flags a candidate microbial mimicry link with Mycobacterium avium subsp. paratuberculosis.

Multi-omics profiling shows new-onset pediatric T1D features reduced butyrate and bile-acid metabolism capacity with increased LPS potential; these shifts associate with worse glycemia and inflammatory signaling and can transfer dysglycemia via FMT in mice, while butyrate is protective and LPS is harmful.

Global-childhood-type-1-diabetes-epidemiology shows rising childhood T1D incidence/prevalence but falling DALYs and mortality from 1990–2021. High-income regions carry the most cases, while Sub-Saharan Africa carries the most harm, and mortality inequality has worsened.

Lipocalin-2 (LCN2/NGAL) is an inflammation-responsive protein central to microbiome–host interactions. It limits bacterial growth by binding iron-scavenging siderophores and is measurable in stool as a noninvasive marker of intestinal inflammation, including IBD.

Serum LCN2 is a sensitive blood biomarker of active ulcerative colitis, mechanistically driven by IL-17A/IL-22/TNF-α synergy in epithelial cells. In Crohn’s disease, IL23R risk alleles associate with lower LCN2, implying genetically constrained antimicrobial responses.

This study shows fecal NGAL is a stable, high-performing stool biomarker for active IBD, comparable to fecal calprotectin, with added biological value because NGAL reflects epithelial as well as neutrophil inflammation.

This mouse study validates fecal lipocalin 2 biomarker as a highly sensitive, non-invasive stool marker that detects low-grade and severe colitis, rises within 1 day of injury, tracks spontaneous IL-10–mediated colitis severity, and declines with mucosal healing.

This study shows that IL-17/IL-22-driven lipocalin-2 shapes inflamed gut ecology by blocking enterochelin-mediated iron uptake, selecting for lipocalin-2–resistant S. Typhimurium with salmochelin (iroBCDE iroN/iroN). Lipocalin-2 thus acts as an inflammatory ecological filter.

24p3/Ngal is shown to bind iron and deliver it into renal cells via receptor-mediated uptake and acidic endosomal trafficking, regulating iron-responsive genes. In embryonic kidney, 24p3 and transferrin target different developmental cell populations, supporting stage-specific iron delivery mechanisms.

Lipocalin 2 sequestrates bacterial siderophores, restricting iron uptake by enterobactin-dependent Enterobacteriaceae. In mice, lipocalin 2 deficiency causes higher E. coli bacteremia and mortality, while bypass siderophores (ferrichrome) overcome protection and S. aureus remains unaffected.

Terpenes and terpenoids are plant isoprenoids that can shape gut microbial ecology and intestinal barrier function. Microbiome studies of limonene, carvacrol, and menthol suggest clinically relevant, compound-specific effects that support emerging microbiome-informed nutrition and therapeutics.

A menthol/limonene/gingerol supplement added to standard care improved IBS/IBS+FD symptoms over 30 days versus placebo, without clear FDR-significant microbiome shifts. Fusobacterium (low abundance) showed the strongest positive correlation with symptom severity, highlighting a potential severity-associated microbiome marker.

In DSS-induced UC rats, D-limonene reduced disease severity and suppressed NF-κB-driven cytokines, COX-2/PGE2, iNOS, MMP-2/9, while improving SOD/GSH and restoring p-ERK1/2. No microbiome data were collected, but pathways align with microbe-triggered inflammation biology.

In an E. coli mouse model, lemon essential oil reduced oxidative stress, cytokines, and duodenal damage while restoring tight junction gene expression. Whole-oil LEO outperformed high-purity d-limonene at similar doses, implying multi-terpene synergy relevant to barrier-focused microbiome phenotyping.

In a mouse CDAD model, carvacrol reduced diarrhea and clinical severity while shifting the microbiome away from Proteobacteria/Enterobacteriaceae blooms and toward Lactobacillaceae/Lachnospiraceae enrichment, without markedly decreasing alpha diversity—highlighting a potential microbiome-sparing prophylactic strategy.

This review explains how plants and microbes produce terpenes and isoprenoids via MVA/MEP pathways and why their chemical diversity supports ecology, therapeutics, nutraceuticals, fragrances, and biofuels. It is microbiome-adjacent through antimicrobial and immunomodulatory bioactivity.

Transferrin is the plasma iron-binding protein that delivers iron to tissues while restricting microbial access to this essential nutrient. Through transferrin receptors and nutritional immunity, transferrin links iron homeostasis to immune defense and microbiome ecology.

This study shows hepcidin cleanly distinguishes ACD from ACD/IDA and predicts oral iron responsiveness. High hepcidin locks iron in macrophages and blocks absorption; low hepcidin restores ferroportin, absorption, and mobilization—an iron-state signature relevant to microbiome ecology.

This review explains how luminal iron availability reshapes gut microbial communities, often enriching Enterobacteriaceae and reducing Bifidobacterium/Lactobacillus, with downstream effects on SCFAs, oxidative stress, inflammation, IBD severity, and pathogen fitness. Iron route (oral vs IV) matters clinically.

This study shows that transferrin-mediated iron sequestration drives nutritional immunity in Drosophila. Toll/Imd pathways induce Tsf1, causing infection-associated hypoferremia. Tsf1 loss increases susceptibility to Pseudomonas and Mucorales, and makes pyoverdine dispensable due to excess iron.

This review on transferrin receptor 1 iron uptake explains how TfR1 imports transferrin-bound iron and how IRP/IRE, HIF, miRNAs, and trafficking pathways tightly regulate receptor levels. These host iron controls indirectly shape microbiome ecology by governing iron availability that selects for iron-scavenging microbes.

Cytochrome c-549 cyclic photophosphorylation in Anacystis nidulans is strongly dependent on redox poise, peaking at ~50% reduced cofactor. Inhibitors implicate plastoquinone and cytochrome f, while CO selectively blocks the cytochrome c-549 pathway.

This review explains how human transferrin binds and releases iron, how receptor-mediated cycling controls delivery, and how transferrin variants and post-translational modifications can disrupt iron handling. These mechanisms shape nutritional immunity and influence transferrin and microbiome interactions via microbial iron competition.

Hepcidin is a liver peptide hormone that controls systemic iron by binding ferroportin and limiting iron export. Inflammation and microbial signals can increase hepcidin, promoting iron restriction and anemia of inflammation. Hepcidin is clinically useful for microbiome-informed evaluation of iron disorders.